MADSEN, Lizell B et al. Reduced price on rotavirus vaccines: enough to facilitate access where most needed?. Bull World Health Organ [online].
vol.90, n.7, pp. 554-556.
2. Fischer Walker CL, Black RE. Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size. BMC Public Health 2011;11(Suppl 3):S16. doi:10.1186/1471-2458-11-S3-S16 PMID:21501433 [ Links ]
3. Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, Parashar UD. Real-world impact of rotavirus vaccination. Pediatr Infect Dis J 2011;30:S1-5. doi:10.1097/INF.0b013e3181fefa1f PMID:21183833 [ Links ]
4. GlaxoSmithKline [Internet]. Millions of children in the world's poorest countries could receive vaccination against rotavirus diarrhoeal disease under new offer made by GSK to the GAVI Alliance. London: GlaxoSmithKline; 2011. Available from: http://www.gsk.com/media/pressreleases/2011/2011-pressrelease-462284.htm [accessed 12 March 2012] [ Links ]
5. Merck & Co. Inc. [Internet]. Merck commends GAVI Alliance on continued efforts to improve access [Internet]. Whitehouse Station: Merck & Co. Inc.; 2011. Available from: http://www.merck.com/newsroom/news-release-archive/corporate-responsibility/2011_0605.html [accessed 12 March 2012] [ Links ]
6. Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. J Infect Dis 2009;200(Suppl 1):S16-27. doi:10.1086/605026 PMID:19817595 [ Links ]
7. United Nations Children's Fund [Internet]. Vaccine price data. New York: United Nations Children's Fund; 2011. Available from: http://www.unicef.org/supply/index_57476.html [accessed 12 March 2012] [ Links ]